The George Institute For Global Health
United Kingdom

News and Events

Friday, 22 November, 2013 - 09:00 to Saturday, 23 November, 2013 - 05:00

The Saïd Business School, Oxford University

Media release: 

The world needs a fundamentally different approach to health care and innovation is the key.

Media release: 

Diabetes is a growing global epidemic killing 4 million people a year and costing $368 billion in healthcare. It affects 366 million people, a number set to increase to 550 million by 2030 if action is not taken.

A multi-disciplinary and international study aimed at exploring service models that provide integrated care to patients with both mental illness and cardiovascular diseases in China has received grants from US National Institute of Mental Health (NIMH).

This Tuesday is World Stroke Day, a reminder that one in six of us will have a stroke in our lifetime. Here the figures are equally alarming with 1.5 million people having a stroke each year, representing about 3,000 to 4,000 people having a stroke each day in India.

Media release: 

Kidney transplant is associated with catastrophic out-of-pocket expenditure in India and pushes the majority of patients who come for treatment to public hospitals into severe financial crisis.

Praveen Devarsetty, Senior Research Fellow at The George Institute, India, and a doctoral student at the University of Sydney, has been awarded the best paper on mobile health at the 2013 Medicine 2.0 conference in London.

The Science of Salt Weekly, an email newsletter that summarizes the latest evidence and research related to dietary salt intake, has been launched to raise more awareness about the risks of eating too much salt.  

Professor Stephen MacMahon, Principal Director of The George Institute for Global Health, has been awarded the 2013 Ernst and Young (EY) Social Entrepreneur of the Year in the Eastern Region category (Australia).

The frequency of industry-sponsored trials in emerging countries is increasing at a rapid rate. In China alone, the number doubled between 2005 and 2010. It is anticipated that emerging markets will soon represent the largest market for global pharmaceutical sales.